| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $123.6M | -23.7% |
| Cost of Revenue | $32.4M | -54.6% |
| Gross Profit | $91.2M | +0.7% |
| R&D Expense | $32.8M | -28.7% |
| SG&A Expense | $50.1M | -0.9% |
| Operating Income | -$21.7M | +56.2% |
| Pre-tax Income | -$878K | +98.0% |
| Income Tax | $249K | +128.4% |
| Net Income | -$6.8M | +84.3% |
| EPS (Basic) | -$0.10 | +58.3% |
| EPS (Diluted) | -$0.10 | +58.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.6M | +3.2% |
| Short-term Investments | $24.7M | -56.0% |
| Accounts Receivable | $8.8M | -49.4% |
| Current Assets | $97.9M | -27.6% |
| Total Assets | $170.0M | -4.5% |
| Current Liabilities | $39.5M | +1.3% |
| Long-term Debt | $0 | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.5M | +188.3% |
| Investing Cash Flow | $18.5M | -59.2% |
| Financing Cash Flow | -$32.6M | -54.7% |
| $41.0M |
| +1.7% |
| Stockholders' Equity | -$30.5M | +45.9% |